Immediate Allogeneic Hematopoietic Stem Cell Transplantation Versus Re-treatment for Patients With High-Risk Acute Myeloid Leukemia

NCT06643195 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

358

Enrollment

OTHER

Sponsor class

Conditions

AML

Interventions

OTHER: ImmediateAllogeneic Hematopoietic Stem Cell Transplantation
OTHER: Retreatment

Sponsor

Institute of Hematology & Blood Diseases Hospital, China